Vitamins & Supplements · Prebiotic fiber group
Prebiotic fibers
Fermentable, non-digestible carbohydrates · also called Prebiotics, prebiotic fiber, fermentable fiber, inulin, FOS, GOS, resistant starch
Prebiotic fibers are plant fibers that gut bacteria use as food. They are sold as powders, capsules and gummies, and added to bars and yogurts. Trials show they raise Bifidobacterium counts and may modestly raise stool frequency, but certainty is low and results differ by fiber. Gas and bloating are common, and they can trigger IBS symptoms, so ask a doctor first.
General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made
About Prebiotic fibers
Prebiotic fibers feed gut bacteria. Trials show clear changes in Bifidobacterium counts, a small possible gain in stool frequency and weak or mixed effects on IBS and blood sugar. Gas and bloating are common, and some people with IBS or Crohn's disease do worse.
What prebiotic fibers are
A prebiotic is a substance that gut microbes use and that has been shown to give a health benefit. Most are fibers. The best known are inulin and FOS (chains of fructose) and GOS (short chains of galactose made from lactose). Guar gum, acacia fiber and resistant starch are also studied.
ISAPP says not all dietary fibers are prebiotics, and that the benefit must be documented. A label that says 'prebiotic' does not by itself show the product was tested.
Where they come from in food
ISAPP names onions, garlic, bananas, chicory root and Jerusalem artichokes, and says the levels in food are typically low. A 2022 review lists wheat, leeks, asparagus, oats, soybeans and artichokes as fructan foods. No source read gave amounts per portion, so none are stated here.
Fibers are also added to bars, yogurts and drinks. Almost all trial results come from isolated fibers, not from eating these foods.
What the research shows
The most consistent finding is more Bifidobacterium in stool. Inulin raised it in 50 trials (not in people with gut disorders), FOS in 8 trials, and fiber mixes in 64 trials in healthy adults. This is a marker, not a health result.
For constipation, a 2025 review of 20 trials found a modest rise in stool frequency, mostly in constipated people, with low certainty. Single small trials of guar gum and acacia fiber point the same way.
For IBS the picture is mixed. Prebiotics and synbiotics did not significantly help in a 2024 analysis, and psyllium, a different fiber, had the clearest benefit in 2026. Resistant starch lowered fasting glucose slightly. FOS did not help Crohn's disease.
Gas, bloating and who should be careful
Gut bacteria ferment these fibers, which makes gas. In a 2022 review, 7 of 17 FOS trials reported gas, while 5 long-term GOS trials found tolerance no different from control in healthy adults. Tolerance depends on the fiber.
Fructans were the most common trigger (56%) and GOS a trigger in 35% of 117 people with IBS in a blinded trial. In children with IBS, fructans worsened symptoms in some. People with IBS, Crohn's disease, ulcerative colitis or a bowel blockage should ask a doctor first. Allergy is rare but a case of anaphylaxis to inulin foods was reported.
At a glance
Traditional uses history, not proof
- Fibers found in onions, garlic, bananas, chicory root and other foods
- Sold as gut-health powders, capsules and gummies
Studied for research
- Gut bacteria (Bifidobacterium), low certainty
- Constipation and stool frequency, low certainty
- IBS symptoms, insufficient evidence (can be a trigger)
- Blood sugar (resistant starch), low certainty
- Respiratory infections in children, low certainty
- Crohn's disease, evidence against
Main compounds
- Inulin
- FOS
- GOS
- Guar gum (PHGG)
- Acacia fiber
- Resistant starch
Common forms
- Powders and capsules
- Gummies and sachets
- Added to bars, yogurts and drinks
- Synbiotics (with a probiotic)
- Foods that contain them
Research links: 2017 ISAPP consensus: definition of a prebiotic · 2023 review: chicory inulin and Bifidobacterium (50 trials) · 2025 review: oligosaccharides and constipation (20 trials) · 2024 analysis: probiotics, prebiotics and IBS · 2022 review: gut effects and tolerance of fibers · Research Library · Genes & Biomarkers Library
What it is and its history
- Accepted scientific name
- Prebiotic fibers (inulin, FOS, GOS, partially hydrolyzed guar gum, acacia fiber, resistant starch and similar)
- Common names
- Prebiotics (English); Prebiotic fiber (English); Fermentable fiber (English); Prebióticos (Spanish); Fibras prebióticas (Spanish)
- Family or group
- A group of non-digestible carbohydrates that gut microbes use. The 2017 ISAPP statement defines a prebiotic as a substrate selectively used by host microorganisms that gives a health benefit; benefit must be documented. A 2022 review describes inulin (chains of fructose, chicory inulin averaging about 12 units), FOS (3 to 9 units), oligofructose (2 to 20 units) and GOS (short chains of galactose, made from lactose).
- Harvest and processing
- Not researched here. The review text read says GOS is created from lactose using enzymes; chicory root is the usual commercial source of inulin (existing summary; not verified).
- Look-alikes and adulterants
- Name: Probiotics; Note: Live bacteria, not fibers. A mix of both is a synbiotic, and a product needs its own evidence.; Name: Psyllium; Note: A thick, less fermentable fiber with its own evidence in IBS; in a 2026 review it was the fiber with the clearest benefit, which was not shown for prebiotics as a group.; Name: Fibers that are not prebiotics; Note: ISAPP says not all dietary fibers are prebiotics. A fiber must be used by gut microbes and give a documented benefit.
- Sustainability and conservation
- Not assessed.
What is inside, and how it may work
What it contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.
Main compounds
| Compound | Family | Where it is concentrated | Activity studied | Level of evidence |
|---|---|---|---|---|
| Inulin | fructan (long fructose chain) | Chicory root, onions, garlic, wheat and many other plants Not read from a source. | Fermented by gut bacteria; raised Bifidobacterium in 50 trials. 12 11 | Human data |
| Fructooligosaccharides (FOS) and oligofructose | short-chain fructan | Plants, or made from inulin Not read from a source. | Raised Bifidobacterium in 8 trials; no benefit in a Crohn's disease trial. 5 1 | Human data |
| Galactooligosaccharides (GOS) | galactose chains made from lactose | Often made from lactose (2022 review) Not read from a source. | Raised Bifidobacterium with fructans in a 64-trial review; beta-GOS improved overall IBS symptoms in 2 trials but also triggered symptoms in 35% of people with IBS in another trial. 14 15 16 | Human data |
| Partially hydrolyzed guar gum (PHGG) | water-soluble fiber from guar | Not read from a source. Not read from a source. | Improved stool form in healthy volunteers with loose stools; lowered laxative use in care-home residents. 20 2 | Human data |
| Acacia fiber | soluble fiber with prebiotic properties | Not read from a source. Not read from a source. | Raised stool frequency in IBS with constipation in one 4-week trial. 8 | Human data |
| Resistant starch | starch that resists digestion | Not read from a source. Not read from a source. | Slightly lowered fasting glucose in a 19-trial review. 19 11 | Human data |
Mechanisms, receptors and pathways
| Target or pathway | Gene or receptor | What was found | Level |
|---|---|---|---|
| Fermentation in the large intestine | Not applicable | These fibers are not digested in the small bowel. Bacteria in the large intestine break them down and make gas (NIDDK), which explains the gas and bloating seen in trials. 23 11 | Human data |
| Bifidobacterium growth | Not applicable | Chicory inulin, FOS and fiber mixes raised Bifidobacterium counts in stool across reviews of 8 to 64 trials. The inulin review found no rise in people with gut disorders. 12 5 14 | Human data |
| Lower stool pH | Not applicable | Oligosaccharides lowered stool pH in 20 trials, a sign of fermentation. Short-chain fatty acid data were inconclusive. 3 | Human data |
| Colon sensitivity in IBS | Not applicable | MRI showed inulin increased colon volume and gas in IBS and healthy people alike; the authors conclude IBS symptoms arise from a gut that is more sensitive to stretching. 10 | Human data |
| Immune function | Not applicable | A review reports fewer respiratory infections in children and higher natural killer cell activity with synbiotics. The mechanism is proposed, not shown in the abstract. 17 | Proposed |
Absorption, metabolism and elimination
- Absorption
- Not absorbed as such; passes to the large intestine undigested.
- Metabolism
- Fermented by gut bacteria.
- Elimination
- Not described in the sources read.
Isolated compounds versus whole extracts
Prebiotics in foods such as onions, garlic, bananas, chicory root and Jerusalem artichokes come with other fibers, starch and plant compounds, and typically at low levels (ISAPP). Almost all trial results here are for isolated or added fibers. No trial comparing food prebiotics with pills was read.
Nutritional composition
No per-portion amounts of prebiotic fiber in foods were found in the sources read (USDA tables were not searched), so none are given. The foods listed come from the ISAPP page and the 2022 review.
1 high certainty6 low certainty1 not enough evidence1 evidence against
What was looked at
The 9 benefits and uses checked for Prebiotic fibers, each with how strong the evidence is. Tap one to open it.
- What prebiotic fibers are and where they come fromHigh certainty
- Feeds Bifidobacterium and other gut bacteriaLow certainty
- Stool frequency and constipationLow certainty
- Stool form and laxative use (guar gum and acacia fiber)Low certainty
- Irritable bowel syndrome (IBS) symptomsNot enough evidence
- Blood sugar markers (resistant starch)Low certainty
- Respiratory infections and immune markersLow certainty
- Prebiotics added to infant formulaLow certainty
- Crohn's diseaseEvidence against
Lab markers tracked in the studies
Bifidobacterium in stoolBowel movements per weekStool form (Bristol scale)Stool pHFasting blood glucoseInsulin resistance score (HOMA-IR)People with at least one respiratory infectionInfant stool pH
What is Prebiotic fibers good for?
The main studied uses and how strong the human evidence is for each. Most results are lab markers or small trials, and they differ from one fiber to another.
Benefits, one by one
Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.
What prebiotic fibers are and where they come from
High certaintyA prebiotic is a food for gut bacteria that has been shown to give a health benefit. Most are fibers. Inulin, FOS and GOS are the best known; partially hydrolyzed guar gum, acacia fiber and resistant starch are also studied. Not every fiber counts as a prebiotic. Onions, garlic, bananas, chicory root and Jerusalem artichokes contain them, usually at low levels.
4 studiesPowders, capsules, gummies, sachets and drink mixes; some are sold wi…
Studies, doses and limits
What the trials found
The 2017 ISAPP consensus statement defines a prebiotic as a substrate selectively used by host microorganisms that gives a health benefit, and says the benefit must be documented before a substance counts as one. The ISAPP resource page says prebiotics are found in onions, garlic, bananas, chicory root and Jerusalem artichokes, typically at low levels, and that not all dietary fibers are prebiotics. A 2022 review describes the chemistry: inulin is a long fructose chain (chicory inulin averages about 12 units), FOS is a shorter chain (3 to 9 units), and GOS is a set of short galactose chains made from lactose. No source read gave amounts of prebiotic fiber per portion of these foods, so none are stated here.
Results
A clear definition and a short food list. Whether a given powder or capsule meets the definition depends on evidence for that exact fiber.
Effect sizes as reported
No effect sizes apply: this describes the ingredient group, not a trial result.
Why this rating
High that this is how scientists define prebiotics and which foods contain them (consensus statement, ISAPP page, review). Not a trial result for any supplement.
Form and dose studied
Powders, capsules, gummies, sachets and drink mixes; some are sold with a probiotic (a synbiotic). Forms are not compared here.
Who was studied
General population.
Limits
Food amounts per portion were not found in the sources read. Different fibers behave differently, so findings for one cannot be moved to another.
Why researchers looked
People see 'prebiotic' on labels and want to know what it means and whether food or powders supply it.
Traditional use
Prebiotic fibers are fermentable plant fibers, not essential nutrients. Fiber is part of a normal diet; that is different from showing that fiber pills treat a condition.
Proposed mechanism Established nutrition
These fibers are not digested in the small intestine. Bacteria in the large intestine ferment them (NIDDK describes this for undigested carbohydrates in general).
A proposed mechanism does not show that the effect happens in people.
Gas and bloating are common with fermentable fibers; see the Safety tab.
Feeds Bifidobacterium and other gut bacteria
Low certaintySeveral reviews found that inulin, FOS and GOS raise the number of Bifidobacterium bacteria in stool. A review of 64 trials in healthy adults found fructans and GOS gave the clearest rises, but overall bacterial diversity did not change. A bacteria count is a lab marker, not a health result.
3 studiesPowders and foods added with chicory inulin or FOS; GOS and mixed fib…
Studies, doses and limits
What the trials found
Chicory inulin-type fructans raised Bifidobacterium (standardised mean difference 0.83, 95% CI 0.58 to 1.08; 50 trials, 2,525 people), except in people with gut disorders. FOS raised it too (weighted mean difference 0.579, 95% CI 0.444 to 0.714; 8 trials, 388 people), and more in adults than in infants. A review of 64 trials in 2,099 healthy adults found Bifidobacterium up (SMD 0.64) and Lactobacillus up (SMD 0.22), with the largest rises for fructans and GOS, and no change in overall diversity.
Results
The one consistent finding across fiber types is more Bifidobacterium in stool. It is a marker only.
Effect sizes as reported
Bifidobacterium SMD 0.83 (inulin), WMD 0.579 (FOS), SMD 0.64 (all fibers, healthy adults).
Why this rating
Low as a health benefit: the result is a bacteria count, trials differ, and no link to better health was shown. The count itself rises reliably.
Form and dose studied
Powders and foods added with chicory inulin or FOS; GOS and mixed fibers in the healthy-adult review.
Who was studied
Healthy adults and several health-problem groups; not people with gut disorders (inulin review).
Limits
A higher count has not been shown to improve symptoms. Stool tests vary. Funding was not stated in the abstracts.
Why researchers looked
Prebiotics are sold to feed helpful gut bacteria, so researchers counted them in stool.
Traditional use
Prebiotic fibers are fermentable plant fibers, not essential nutrients. Fiber is part of a normal diet; that is different from showing that fiber pills treat a condition.
Proposed mechanism Established nutrition
Bacteria in the large intestine ferment these fibers and grow on them. This is established for Bifidobacterium counts, but not shown to cause better health.
A proposed mechanism does not show that the effect happens in people.
Gas and bloating are common with fermentable fibers; see the Safety tab.
Stool frequency and constipation
Low certaintyA 2025 review of 20 trials of seven oligosaccharide types found a modest rise in how often people go, larger in constipated people. Stool consistency overall did not change significantly, and the authors rate certainty as low. In a chicory inulin review, bowel function improved in healthy people.
3 studiesSeven oligosaccharide types pooled; chicory inulin and FOS studied se…
Studies, doses and limits
What the trials found
The 2025 review pooled 20 randomised trials (1,786 people). Stool frequency rose overall, with a larger effect in constipated people (SMD 0.99, 95% CI 0.58 to 1.28) than in others (SMD 0.30, 95% CI 0.10 to 0.51). Shorter trials (3 weeks or less) showed bigger gains (SMD 0.89) than longer ones (SMD 0.24). Stool consistency improved in constipated people (SMD 0.46) but not overall. The chicory inulin review found bowel function better in healthy people without giving numbers in its abstract. A 2022 tolerance review found 4 of 17 FOS and oligofructose trials reported better stool frequency, and in 5 long-term GOS trials in healthy adults stool frequency did not change.
Results
Modest, short-lived gains in how often people go, mostly in constipated people. GOS alone did not change it in healthy adults.
Effect sizes as reported
Stool frequency SMD 0.99 (constipated) and 0.30 (others); larger early than late.
Why this rating
Low: the review authors call certainty low because trials differ and have limits; gains shrink in longer trials; the effect depends on the fiber.
Form and dose studied
Seven oligosaccharide types pooled; chicory inulin and FOS studied separately.
Who was studied
People with and without constipation.
Limits
The pooled review mixes fibers. It does not show which one works. Gas and bloating can make people stop.
Why researchers looked
Fermentable fibers add to stool bulk and water, so they are tried for constipation.
Traditional use
Prebiotic fibers are fermentable plant fibers, not essential nutrients. Fiber is part of a normal diet; that is different from showing that fiber pills treat a condition.
Proposed mechanism Proposed
Not fully established. Fermentation changes stool water and bacteria; the reviews report a fall in stool pH, a fermentation marker.
A proposed mechanism does not show that the effect happens in people.
Gas and bloating are common with fermentable fibers; see the Safety tab.
Stool form and laxative use (guar gum and acacia fiber)
Low certaintyTwo small trials looked at partially hydrolyzed guar gum (PHGG). In 44 healthy people with loose stools, stool form moved toward normal over 3 months. In 52 care-home residents with constipation, bowel frequency did not change but laxative use fell. A 180-person trial of acacia fiber in IBS with constipation found more frequent stools but no change in stool consistency.
3 studiesPartially hydrolyzed guar gum and acacia fiber; amounts appear in the…
Studies, doses and limits
What the trials found
PHGG for 3 months improved stool form against placebo (Bristol scale) with no change in stool frequency, and raised Bifidobacterium (p<0.05) in 44 healthy volunteers with loose stools. In 52 long-term care residents, 4 weeks of PHGG did not change bowel frequency or stool form, but lowered use of lactulose, senna and total laxatives in weeks 3 and 4, and side effects did not differ. In 180 adults with IBS and constipation, 4 weeks of acacia fiber raised stool frequency against placebo (P<0.001) but stool consistency, stool mass and quality of life did not change significantly.
Results
Mixed, small and different outcomes in different groups.
Effect sizes as reported
PHGG: stool form better (healthy, loose stools); fewer laxatives (care home); acacia: stool frequency better (IBS with constipation).
Why this rating
Low: each result comes from one small or one-fiber trial, and the outcomes differ.
Form and dose studied
Partially hydrolyzed guar gum and acacia fiber; amounts appear in the studies table only.
Who was studied
Healthy adults with loose stools; older adults in care; adults with IBS and constipation.
Limits
Single trials, 4 weeks to 3 months. Do not apply results to other fibers. Care-home residents kept using their own laxatives.
Why researchers looked
PHGG and acacia fiber are soluble fibers that gut bacteria ferment, sold for regularity.
Traditional use
Prebiotic fibers are fermentable plant fibers, not essential nutrients. Fiber is part of a normal diet; that is different from showing that fiber pills treat a condition.
Proposed mechanism Not established
Not established. The PHGG trial reported a Bifidobacterium rise; whether that explains the stool change was not tested.
A proposed mechanism does not show that the effect happens in people.
Gas and bloating are common with fermentable fibers; see the Safety tab.
Irritable bowel syndrome (IBS) symptoms
Not enough evidenceThere is no dependable benefit for IBS from prebiotics as a group. A 2024 network analysis found prebiotics and synbiotics did not significantly help. A 2026 fiber review found psyllium (not a prebiotic) helped, and beta-GOS improved overall symptoms in 2 trials. Fructans and GOS also triggered symptoms in many people with IBS.
4 studiesPsyllium, inulin-type fructans, beta-GOS, acacia fiber, agave fructan…
Studies, doses and limits
What the trials found
A 2024 network meta-analysis (7 prebiotic or synbiotic trials among 67) found probiotics and fecal transplant helped IBS but prebiotics and synbiotics did not show significant improvement. A 2026 review of 30 trials (1,904 people) found 52% responded to fiber and 44% to placebo (RR 1.21), with a benefit for psyllium (RR 1.53); overall symptom scores did not change significantly, except for beta-GOS (2 trials). A systematic review of 10 small trials found seven reported better symptoms and one worse; agave fructans improved constipation but worsened flatulence. In a blinded challenge trial in 117 people with IBS, fructans were the most common trigger (56%) and GOS triggered symptoms in 35%.
Results
Results point in different directions depending on the fiber. Some people with IBS react badly to fermentable fibers.
Effect sizes as reported
Fiber response RR 1.21 (all fibers); psyllium RR 1.53; prebiotics and synbiotics not significant in the network analysis.
Why this rating
Insufficient for prebiotic fibers as a group: results are mixed, trials are small, and fermentable fibers can worsen symptoms. Only psyllium has a clear benefit, and it is a different kind of fiber.
Form and dose studied
Psyllium, inulin-type fructans, beta-GOS, acacia fiber, agave fructans and others across reviews.
Who was studied
Adults with IBS.
Limits
Small, short trials; large differences between trials; subtypes of IBS could not be separated.
Why researchers looked
Fiber is widely used and recommended in IBS, so prebiotics have been tested.
Traditional use
Prebiotic fibers are fermentable plant fibers, not essential nutrients. Fiber is part of a normal diet; that is different from showing that fiber pills treat a condition.
Proposed mechanism Disputed
Not established. Fermentation makes gas and stretches the bowel, which may help some people and bother others.
A proposed mechanism does not show that the effect happens in people.
Fermentable fibers can trigger IBS symptoms; see the Safety tab.
Blood sugar markers (resistant starch)
Low certaintyA review of 19 trials found resistant starch lowered fasting blood glucose by a small amount (about 0.09 mmol/L) compared with ordinary digestible starch, and lowered an insulin-resistance score. Several other insulin measures did not change. This result is for resistant starch, not for inulin, FOS or GOS.
1 studiesResistant starch compared with digestible starch; amounts are in the …
Studies, doses and limits
What the trials found
The review pooled 19 randomised trials of resistant starch (types 1 and mixtures with other ingredients were excluded). Fasting glucose fell by 0.09 mmol/L (95% CI -0.13 to -0.04). The fall was larger in longer trials (over 8 weeks, -0.12 mmol/L) and in trials with higher amounts (-0.16 mmol/L; see the studies table). The insulin-resistance score HOMA-IR fell (-0.33, 95% CI -0.51 to -0.14). Fasting insulin, four measures from an intravenous glucose test and HOMA-beta did not change. The authors describe the effects as moderate.
Results
A small average fall in fasting glucose, with mixed results for insulin measures. No result for diabetes outcomes such as HbA1c in this abstract.
Effect sizes as reported
Fasting glucose -0.09 mmol/L; HOMA-IR -0.33.
Why this rating
Low: the effect is small, trials differ in people and amounts, the abstract gives no certainty rating, and the result applies only to resistant starch.
Form and dose studied
Resistant starch compared with digestible starch; amounts are in the studies table only.
Who was studied
Adults in 19 trials; the abstract does not say whether they were healthy or had diabetes.
Limits
No rating of study quality in the abstract. A glucose marker is not the same as better health.
Why researchers looked
Resistant starch is digested slowly or fermented in the large bowel, so it was tested for blood sugar control.
Traditional use
Prebiotic fibers are fermentable plant fibers, not essential nutrients. Fiber is part of a normal diet; that is different from showing that fiber pills treat a condition.
Proposed mechanism Not established
Not established. Fermentation products and slower digestion are suggested; the review abstract does not test them.
A proposed mechanism does not show that the effect happens in people.
Gas can occur as resistant starch is fermented. People using diabetes medicines should ask a pharmacist or doctor before adding a fiber product.
Respiratory infections and immune markers
Low certaintyA 2022 review of 58 studies, mostly in infants and children, found fewer people had at least one respiratory infection with prebiotics (mostly oligosaccharides) than with placebo. The authors say there is less evidence in adults. Effects on immune cell types were less clear.
1 studiesMainly oligosaccharides (such as FOS and GOS), alone or with probioti…
Studies, doses and limits
What the trials found
The meta-analysis found the number of people with one or more respiratory infections was lower with prebiotics (odds ratio 0.73, 95% CI 0.62 to 0.86; 17 comparisons) and with synbiotics (OR 0.75; 9 comparisons) than with placebo. Natural killer cell activity was higher with synbiotics (3 comparisons). Most studies were randomised trials in infants and children.
Results
Fewer infections reported in children, a promising but uncertain signal that is not shown in adults.
Effect sizes as reported
Respiratory infection OR 0.73 (prebiotics).
Why this rating
Low: mostly infant and child trials, no certainty rating in the abstract, infection reports can be unreliable, and adult evidence is thin.
Form and dose studied
Mainly oligosaccharides (such as FOS and GOS), alone or with probiotics.
Who was studied
Mostly infants and children.
Limits
Different products and outcomes pooled. Funding was not stated in the abstract.
Why researchers looked
Gut bacteria and their by-products influence the immune system, so prebiotics were tested against infections.
Traditional use
Prebiotic fibers are fermentable plant fibers, not essential nutrients. Fiber is part of a normal diet; that is different from showing that fiber pills treat a condition.
Proposed mechanism Proposed
Proposed: changes in gut bacteria and short-chain fatty acids may alter immune activity. The abstract does not test this.
A proposed mechanism does not show that the effect happens in people.
Do not give prebiotic supplements to babies or children without a doctor's advice; see the Safety tab.
Prebiotics added to infant formula
Low certaintyA 2025 review of 30 articles (5,290 infants) found infant formula with added prebiotics raised Bifidobacterium counts and lowered stool pH compared with standard formula, and growth was not harmed. This is about regulated infant formula, not supplements.
1 studiesPrebiotics (such as FOS and GOS) in cow's-milk-based infant formula.
Studies, doses and limits
What the trials found
In infants aged 6 months or less, prebiotic formula raised Bifidobacterium (mean difference 0.49, 95% CI 0.27 to 0.71; 7 comparisons) and lowered stool pH (mean difference -0.39, 95% CI -0.57 to -0.20) against standard formula. Against human milk, total bacteria were higher with the prebiotic formula and weight-for-age was slightly higher. Effects on Lactobacillus were inconsistent. The authors conclude prebiotics in formula can change gut bacteria without negative effects on growth. The abstract gives no detail on side effects.
Results
A bacterial and stool pH change in formula-fed babies, with no growth harm shown.
Effect sizes as reported
Bifidobacterium MD 0.49; stool pH MD -0.39.
Why this rating
Low: markers only in babies, no certainty rating in the abstract, and the authors ask for better-quality trials.
Form and dose studied
Prebiotics (such as FOS and GOS) in cow's-milk-based infant formula.
Who was studied
Infants aged 6 months or less.
Limits
Applies to regulated infant formula only. It does not support giving prebiotic powders or supplements to babies.
Why researchers looked
Prebiotics are added to formula to copy the oligosaccharides in human milk.
Traditional use
Prebiotic fibers are fermentable plant fibers, not essential nutrients. Fiber is part of a normal diet; that is different from showing that fiber pills treat a condition.
Proposed mechanism Proposed
Proposed: bacteria in the infant gut use the added oligosaccharides. The abstract reports the bacteria and pH changes but not why.
A proposed mechanism does not show that the effect happens in people.
Ask a pediatrician before giving any fiber or prebiotic product to a baby.
Crohn's disease
Evidence againstOne well-powered trial in 103 people with active Crohn's disease found no clinical benefit from FOS over 4 weeks. 22% responded on FOS and 39% on placebo, and more people on FOS dropped out. This is evidence against FOS for Crohn's disease.
1 studiesFOS compared with a non-prebiotic placebo; amount in the studies tabl…
Studies, doses and limits
What the trials found
In 103 people with active Crohn's disease, FOS for 4 weeks did not improve clinical response against placebo (12 of 54 against 19 of 49, p=0.067). Dropouts before week 4 were 26% on FOS and 8% on placebo. Bifidobacteria and Faecalibacterium prausnitzii in stool did not differ. FOS changed some immune cell measures in the gut lining.
Results
No benefit; the placebo group did numerically better.
Effect sizes as reported
Response 22% FOS vs 39% placebo (not significant).
Why this rating
Against: an adequately powered placebo-controlled trial found no benefit and more dropouts on FOS. One trial and one fiber only.
Form and dose studied
FOS compared with a non-prebiotic placebo; amount in the studies table only.
Who was studied
Adults with active Crohn's disease.
Limits
One trial, 4 weeks. Other prebiotics were not tested.
Why researchers looked
Gut bacteria are thought to drive inflammation in Crohn's disease, and FOS raised Bifidobacterium in earlier small studies.
Traditional use
Prebiotic fibers are fermentable plant fibers, not essential nutrients. Fiber is part of a normal diet; that is different from showing that fiber pills treat a condition.
Proposed mechanism Not established
Not shown: FOS changed some immune cells in the gut lining, but bacteria counts did not change.
A proposed mechanism does not show that the effect happens in people.
People with Crohn's disease or ulcerative colitis should ask their gut specialist before using fiber supplements.
Connections to the rest of health
How Prebiotic fibers connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.
Explore every connection: goals, body systems, organs, symptoms, genes
A. Wellness goals
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Gut Health | High certainty | What prebiotic fibers are and where they come from: A prebiotic is a food for gut bacteria that has been shown to give a health benefit. Most are fibers. Inulin, FOS and GOS are the best known; partially hydrolyzed guar gum, acacia fiber and resistant starch are also studied. Not every fiber counts as a prebiotic. Onions, garlic, bananas, chicory root and Jerusalem artichokes contain them, usually at low levels. | 7 21 11 23 | |
| Digestive Support | High certainty | What prebiotic fibers are and where they come from: A prebiotic is a food for gut bacteria that has been shown to give a health benefit. Most are fibers. Inulin, FOS and GOS are the best known; partially hydrolyzed guar gum, acacia fiber and resistant starch are also studied. Not every fiber counts as a prebiotic. Onions, garlic, bananas, chicory root and Jerusalem artichokes contain them, usually at low levels. | 7 21 11 23 | |
| Gut Health | Low certainty | Feeds Bifidobacterium and other gut bacteria: Several reviews found that inulin, FOS and GOS raise the number of Bifidobacterium bacteria in stool. A review of 64 trials in healthy adults found fructans and GOS gave the clearest rises, but overall bacterial diversity did not change. A bacteria count is a lab marker, not a health result. Stool frequency and constipation: A 2025 review of 20 trials of seven oligosaccharide types found a modest rise in how often people go, larger in constipated people. Stool consistency overall did not change significantly, and the authors rate certainty as low. In a chicory inulin review, bowel function improved in healthy people. | 12 5 14 3 11 18 15 13 16 9 | |
| Microbiome Balance | Low certainty | Feeds Bifidobacterium and other gut bacteria: Several reviews found that inulin, FOS and GOS raise the number of Bifidobacterium bacteria in stool. A review of 64 trials in healthy adults found fructans and GOS gave the clearest rises, but overall bacterial diversity did not change. A bacteria count is a lab marker, not a health result. Prebiotics added to infant formula: A 2025 review of 30 articles (5,290 infants) found infant formula with added prebiotics raised Bifidobacterium counts and lowered stool pH compared with standard formula, and growth was not harmed. This is about regulated infant formula, not supplements. | 12 5 14 9 | |
| Digestive Support | Low certainty | Stool frequency and constipation: A 2025 review of 20 trials of seven oligosaccharide types found a modest rise in how often people go, larger in constipated people. Stool consistency overall did not change significantly, and the authors rate certainty as low. In a chicory inulin review, bowel function improved in healthy people. Irritable bowel syndrome (IBS) symptoms: There is no dependable benefit for IBS from prebiotics as a group. A 2024 network analysis found prebiotics and synbiotics did not significantly help. A 2026 fiber review found psyllium (not a prebiotic) helped, and beta-GOS improved overall symptoms in 2 trials. Fructans and GOS also triggered symptoms in many people with IBS. | 3 12 11 18 15 13 16 | |
| Digestive Support | Low certainty | Stool form and laxative use (guar gum and acacia fiber): Two small trials looked at partially hydrolyzed guar gum (PHGG). In 44 healthy people with loose stools, stool form moved toward normal over 3 months. In 52 care-home residents with constipation, bowel frequency did not change but laxative use fell. A 180-person trial of acacia fiber in IBS with constipation found more frequent stools but no change in stool consistency. | 20 2 8 | |
| Gut Health | Low certainty | Stool form and laxative use (guar gum and acacia fiber): Two small trials looked at partially hydrolyzed guar gum (PHGG). In 44 healthy people with loose stools, stool form moved toward normal over 3 months. In 52 care-home residents with constipation, bowel frequency did not change but laxative use fell. A 180-person trial of acacia fiber in IBS with constipation found more frequent stools but no change in stool consistency. Crohn's disease: One well-powered trial in 103 people with active Crohn's disease found no clinical benefit from FOS over 4 weeks. 22% responded on FOS and 39% on placebo, and more people on FOS dropped out. This is evidence against FOS for Crohn's disease. | 20 2 8 1 | |
| Blood Sugar Balance | Low certainty | Blood sugar markers (resistant starch): A review of 19 trials found resistant starch lowered fasting blood glucose by a small amount (about 0.09 mmol/L) compared with ordinary digestible starch, and lowered an insulin-resistance score. Several other insulin measures did not change. This result is for resistant starch, not for inulin, FOS or GOS. | 19 | |
| Metabolic Health | Low certainty | Blood sugar markers (resistant starch): A review of 19 trials found resistant starch lowered fasting blood glucose by a small amount (about 0.09 mmol/L) compared with ordinary digestible starch, and lowered an insulin-resistance score. Several other insulin measures did not change. This result is for resistant starch, not for inulin, FOS or GOS. | 19 | |
| Immune Support | Low certainty | Respiratory infections and immune markers: A 2022 review of 58 studies, mostly in infants and children, found fewer people had at least one respiratory infection with prebiotics (mostly oligosaccharides) than with placebo. The authors say there is less evidence in adults. Effects on immune cell types were less clear. | 17 |
B. Body systems
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Digestive System | Biological association | High certainty | Studied for: What prebiotic fibers are and where they come from Studied for: Feeds Bifidobacterium and other gut bacteria | 7 21 11 23 12 5 14 3 20 2 8 18 15 13 16 19 9 1 |
| Nutrition | Biological association | High certainty | Studied for: What prebiotic fibers are and where they come from | 7 21 11 23 |
| Gut Health | Biological association | Low certainty | Studied for: Feeds Bifidobacterium and other gut bacteria Studied for: Prebiotics added to infant formula | 12 5 14 9 |
| Metabolism Weight | Biological association | Low certainty | Studied for: Blood sugar markers (resistant starch) | 19 |
| Immune System | Biological association | Low certainty | Studied for: Respiratory infections and immune markers Studied for: Crohn's disease | 17 1 |
| Respiratory System | Biological association | Low certainty | Studied for: Respiratory infections and immune markers | 17 |
E. Health conditions
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Irritable bowel syndrome | Documented risk | Fructans and GOS were common triggers in a blinded IBS trial. Preparation or compound: Fructans and GOS |
16 10 | |
| Gas and bloating | Adverse effect or risk | Documented risk | Bacterial fermentation makes gas. Preparation or compound: Fermentable fibers |
11 23 |
| Crohn's disease | Evidence against | No clinical benefit and more dropouts in an adequately powered trial. No benefit and more dropouts with FOS in a 103-person trial. Preparation or compound: FOS |
1 | |
| Allergy to inulin or chicory | Adverse effect or risk | Case report | A rare anaphylaxis case report. Preparation or compound: Inulin-containing foods |
6 |
| Constipation | Preliminary | Modest rise in stool frequency in a 20-trial review; low certainty. Preparation or compound: Oligosaccharides |
3 |
I. Biomarkers
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Bifidobacterium in stool | Biological association | Low certainty | Measured in trials: higher in most trials. A lab change is not the same as a health benefit. | 12 5 14 |
| Bowel movements per week | Biological association | Low certainty | Measured in trials: higher in some trials. A lab change is not the same as a health benefit. | 3 8 |
| Stool form (Bristol scale) | Biological association | Low certainty | Measured in trials: better in one trial, no change in others. A lab change is not the same as a health benefit. | 20 2 |
| Stool pH | Biological association | Low certainty | Measured in trials: lower. A lab change is not the same as a health benefit. | 3 |
| Fasting blood glucose | Biological association | Low certainty | Measured in trials: slightly lower. A lab change is not the same as a health benefit. | 19 |
| Insulin resistance score (HOMA-IR) | Biological association | Low certainty | Measured in trials: lower. A lab change is not the same as a health benefit. | 19 |
| People with at least one respiratory infection | Biological association | Low certainty | Measured in trials: fewer with prebiotics. A lab change is not the same as a health benefit. | 17 |
| Infant stool pH | Biological association | Low certainty | Measured in trials: lower with prebiotic formula. A lab change is not the same as a health benefit. | 9 |
K. Biological pathways
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Bifidobacterium | Preliminary mechanism | Human | Abundance rose with inulin, FOS and fiber mixes in several reviews. | 12 5 14 |
| Lactobacillus | Preliminary mechanism | Human | Rose in a 64-trial review of fibers in healthy adults; inconsistent in infant formula trials. | 14 9 |
L. Active compounds
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Inulin | Biological association | Human | Fermented by gut bacteria; raised Bifidobacterium in 50 trials. Preparation or compound: Chicory root, onions, garlic, wheat and many other plants |
12 11 |
| Fructooligosaccharides (FOS) and oligofructose | Biological association | Human | Raised Bifidobacterium in 8 trials; no benefit in a Crohn's disease trial. Preparation or compound: Plants, or made from inulin |
5 1 |
| Galactooligosaccharides (GOS) | Biological association | Human | Raised Bifidobacterium with fructans in a 64-trial review; beta-GOS improved overall IBS symptoms in 2 trials but also triggered symptoms in 35% of people with IBS in another trial. Preparation or compound: Often made from lactose (2022 review) |
14 15 16 |
| Partially hydrolyzed guar gum (PHGG) | Biological association | Human | Improved stool form in healthy volunteers with loose stools; lowered laxative use in care-home residents. Preparation or compound: Not read from a source. |
20 2 |
| Acacia fiber | Biological association | Human | Raised stool frequency in IBS with constipation in one 4-week trial. Preparation or compound: Not read from a source. |
8 |
| Resistant starch | Biological association | Human | Slightly lowered fasting glucose in a 19-trial review. Preparation or compound: Not read from a source. |
19 11 |
Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 26, 2026).
Evidence at a glance: what the research found for 9 outcomes
Each outcome below is one thing researchers measured. Certainty is how far the evidence can be trusted, not how well it works. The full studies are on the next tab.
The evidence
The research centre for Prebiotic fibers. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.
Evidence by outcome
Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).
How we rate evidence
High certainty
Several well-run trials or reviews agree; further research is unlikely to change the picture much.
Moderate certainty
Good trials point the same way, but some doubt remains.
Low certainty
Small, short or inconsistent trials. The finding could change with better research.
Very low certainty
Very little or very weak human data. Treat as a possibility only.
Mixed findings
Trials or reviews disagree with each other.
Not enough evidence
Not enough human research to say either way.
Evidence against
Good research found no benefit, or found harm.
We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We started from our existing summary of prebiotic fibers, then re-read PubMed abstracts for reviews, trials and case reports, the open-access text of the 2022 tolerance review, and the ISAPP, NIDDK and NHS pages. Only abstracts were read for most studies.
Study library: every study we checked 23
| Study | Design | People | Product, dose, length | Result |
|---|---|---|---|---|
| Benjamin 2011 Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut · PMID 21262918 · DOI |
Randomized controlled trial |
103 103 people with active Crohn's disease |
Fructo-oligosaccharides (FOS) 15 g a day 4 weeks · vs Non-prebiotic placebo |
No clinical benefit. Clinical response was 22% with FOS and 39% with placebo (p=0.067, not significant). More people on FOS dropped out (26% against 8%). Bifidobacteria counts did not differ. Response 12 of 54 vs 19 of 49; dropouts 14 vs 4 (Not given in the abstract) Methods, limits and fundingOutcomes: Clinical response (fall of 70 or more points on the Crohn's activity index); bacteria counts; immune cells Limitations: One trial, 4 weeks. Adequately powered according to its authors. The result went against FOS. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Chan 2022 Effectiveness of Partially Hydrolyzed Guar Gum in Reducing Constipation in Long Term Care Facility Residents: A Randomized Single-Blinded Placebo-Controlled Trial. J Nutr Health Aging · PMID 35297467 · DOI |
Randomized controlled trial |
52 52 long-term care residents in Hong Kong with chronic constipation (average age about 84) |
Partially hydrolyzed guar gum (PHGG) in water 5 g a day 4 weeks · vs Water only |
Bowel frequency and stool form did not differ from control. Laxative use was lower in the PHGG group in weeks 3 and 4. Adverse effects did not differ. No difference in frequency or form; less laxative use at weeks 3 and 4 (Not given in the abstract) Methods, limits and fundingOutcomes: Bowel frequency, stool form, laxative use, adverse events Limitations: Small, single-blinded, 4 weeks, one setting. Residents kept using their own laxatives. Funding and conflicts: Not stated in the abstract. Registration: NCT05037565 Read: abstract |
| Chen 2025 Non-Digestible Oligosaccharides and Constipation: A Systematic Review and Meta-Analysis of Randomized Trials on Stool Frequency, Stool Consistency, and Fermentation Biomarkers. Nutrients · PMID 41156499 · DOI |
Systematic review meta analysis |
1786 20 randomised trials; seven types of non-digestible oligosaccharide (not one fiber alone) |
Non-digestible oligosaccharides (such as FOS, GOS, inulin) Subgroups: up to 3 weeks, and longer · vs Placebo |
Stool frequency rose, more in constipated people than in others. Stool consistency overall did not change significantly. Fecal pH fell. Short-chain fatty acid data were inconclusive. Stool frequency SMD 0.99 (constipated), 0.30 (not constipated); fecal pH SMD -1.02 (95% CI 0.58 to 1.28; 0.10 to 0.51; -1.25 to -0.79) Methods, limits and fundingOutcomes: Stool frequency, stool consistency, fecal pH, short-chain fatty acids Limitations: The authors rate certainty as low (mixed trials, study limitations). Short trials showed larger gains than long ones. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Chumpitazi 2018 Fructans Exacerbate Symptoms in a Subset of Children With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol · PMID 28970147 · DOI |
Randomized controlled trial |
23 23 children with IBS |
Fructan-containing meals 0.5 g/kg, maximum 19 g (per the trial) 72 hours per period (crossover) · vs Maltodextrin |
More abdominal pain (3.4 against 2.4 episodes a day), more bloating and more gas with fructans. 12 of 23 qualified as fructan sensitive. Sensitivity could not be predicted from usual symptoms. Pain episodes 3.4 vs 2.4 a day (Not given in the abstract) Methods, limits and fundingOutcomes: Abdominal pain, bloating, flatulence, breath gas Limitations: Small crossover trial; short; children with IBS only. Funding and conflicts: Not stated in the abstract. Registration: NCT02842281 Read: abstract |
| Dou 2022 Effect of Fructooligosaccharides Supplementation on the Gut Microbiota in Human: A Systematic Review and Meta-Analysis. Nutrients · PMID 36014803 · DOI |
Systematic review meta analysis |
388 8 randomised trials (213 people on FOS, 175 controls); adults and infants |
Fructooligosaccharides (FOS) Subgroups: 5 g or less, and more than 5 g, a day 4 weeks or less, and over 4 weeks · vs Control |
Bifidobacterium counts rose with FOS (weighted mean difference 0.579). The rise was larger in adults than in infants. No differences from control were found for other tested bacteria or for gut symptoms. Bifidobacterium: weighted mean difference 0.579 (95% CI 0.444 to 0.714) Methods, limits and fundingOutcomes: Gut bacteria counts; gut symptoms such as bloating and gas Limitations: Only 8 trials. A bacteria count is a lab marker, not a health result. The authors say higher amounts and longer use showed clearer effects; that is a finding, not advice. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Franck 2005 Anaphylactic reaction to inulin: first identification of specific IgEs to an inulin protein compound. Int Arch Allergy Immunol · PMID 15650313 · DOI |
Case report |
1 One woman with a past artichoke allergy |
Two health foods containing inulin |
Two immediate allergic reactions, one a severe anaphylactic shock, after eating two health foods containing inulin. Tests pointed to inulin bound to protein. Single case (Not applicable) Methods, limits and fundingOutcomes: Allergic reaction and antibody tests Limitations: A single case report. How often this happens is not known. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Gibson 2017 Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol · PMID 28611480 · DOI |
Consensus statement |
Expert panel of microbiology, nutrition and clinical research | Prebiotics (definition) |
The panel defined a prebiotic as a substrate selectively used by host microorganisms that gives a health benefit. Beneficial health effects must be documented before a substance counts as a prebiotic. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Definition and scope of the word 'prebiotic' Limitations: A definition, not a trial. It does not say which products meet it. Funding and conflicts: Not stated in the abstract. Read: abstract |
| JanssenDuijghuijsen 2024 Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial. Eur J Nutr · PMID 38653808 · DOI |
Randomized controlled trial |
180 180 adults with IBS and constipation (Rome IV) |
Acacia fiber (prebiotic properties), or a Bifidobacterium lactis probiotic 10 g acacia fiber a day (probiotic 4 g) 4 weeks · vs Maltodextrin placebo |
Stool frequency improved with acacia fiber against placebo (P<0.001). Stool consistency, stool mass and quality of life did not change significantly. The probiotic, not the fiber, lowered IBS symptom severity. Stool frequency better than placebo (P<0.001) (Not given in the abstract) Methods, limits and fundingOutcomes: Stool pattern, IBS symptoms, quality of life Limitations: One fiber, 4 weeks. Do not apply to other fibers. Funding and conflicts: Not stated in the abstract. Registration: NCT04798417 Read: abstract |
| Kebbe 2025 Effects of Infant Formula Supplemented With Prebiotics on the Gut Microbiome, Gut Environment, Growth Parameters, and Safety and Tolerance: A Systematic Review and Meta-Analysis. Nutr Rev · PMID 39832301 · DOI |
Systematic review meta analysis |
5290 30 articles of randomised trials in infants aged 6 months or less |
Prebiotics added to cow's-milk-based infant formula Various · vs Standard formula or human milk |
Prebiotic formula raised Bifidobacterium (mean difference 0.49) and lowered stool pH (-0.39) compared with standard formula. Growth was not harmed. Effects on Lactobacillus were inconsistent. Bifidobacterium MD 0.49; stool pH MD -0.39 (95% CI 0.27 to 0.71; -0.57 to -0.20) Methods, limits and fundingOutcomes: Gut bacteria, stool pH, growth, safety and tolerance Limitations: Infant formula only, a regulated product that is not a supplement. The abstract gives no detail on side effects. The authors call for higher-quality research. Funding and conflicts: Not stated in the abstract. Registration: PROSPERO CRD42021253589 Read: abstract |
| Major 2017 Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome. Gastroenterology · PMID 27746233 · DOI |
Randomized controlled trial |
58 29 adults with IBS and 29 healthy controls |
Inulin drink (40 g of carbohydrate), fructose drink, or glucose drink 40 g in a 500 mL drink, one time 300 minutes of follow-up · vs Glucose drink |
More people with IBS reached the symptom threshold after inulin (13 of 29) than after glucose (6 of 29). Inulin increased colon volume and gas in both people with IBS and controls. 13 of 29 after inulin vs 6 of 29 after glucose (Not given in the abstract) Methods, limits and fundingOutcomes: Symptoms, MRI of bowel contents, breath hydrogen Limitations: Single large drinks, not daily use. Inulin only; other prebiotics were not tested. Funding and conflicts: Not stated in the abstract. Registration: NCT01776853 Read: abstract |
| Mysonhimer 2022 Gastrointestinal Effects and Tolerance of Nondigestible Carbohydrate Consumption. Adv Nutr · PMID 36041173 · DOI |
Systematic review |
103 clinical trials in adults without gut disease (17 on inulin, 17 on FOS or oligofructose, 5 long-term trials on GOS) | Nondigestible carbohydrates that the US FDA accepts as dietary fibers, including inulin, FOS, oligofructose and GOS Studied from 0.75 to 160 g a day across all fibers A single meal to 28 weeks · vs Various |
Tolerance depended on the specific fiber. Of 17 FOS and oligofructose trials, 4 reported better stool frequency and 7 reported gas. In 5 long-term GOS trials, stool frequency did not change and tolerance did not differ from control in healthy adults. Counts of trials, not pooled (Not applicable) Methods, limits and fundingOutcomes: Bloating, gas, rumbling; stool frequency and consistency Limitations: Counts of studies, not a pooled analysis. Adults without gut disease only. Open-access full text read for the FOS, GOS, inulin and infant sections. Funding and conflicts: Not stated in the abstract. Read: full-text (open access, PMC9776669) |
| Nagy 2023 Effect of chicory-derived inulin-type fructans on abundance of Bifidobacterium and on bowel function: a systematic review with meta-analyses. Crit Rev Food Sci Nutr · PMID 35833477 · DOI |
Systematic review meta analysis |
2525 50 randomised trials, people aged 0 to 83 (healthy and with health problems) |
Chicory-derived inulin-type fructans (foods or supplements) Chicory root Studied at 3 to 20 g a day At least 7 days · vs Placebo or control |
Bifidobacterium abundance rose overall, in healthy people and in several health-problem groups, but not in people with gut disorders. Bowel function improved in healthy people. Bifidobacterium: standardised mean difference 0.83 (95% CI 0.58 to 1.08 (50 studies, 2,525 people)) Methods, limits and fundingOutcomes: Bifidobacterium abundance in stool; bowel function Limitations: Abstract gives no GRADE rating and no bowel-function numbers. A bacteria count is a lab marker, not a symptom. Funding and conflicts: Not stated in the abstract. Registration: PROSPERO CRD42020162892 Read: abstract |
| Raked 2026 Fibre manipulation to manage symptom severity and quality of life in patients with functional bowel disorders: A systematic review. Clin Nutr ESPEN · PMID 41525871 · DOI |
Systematic review |
10 randomised trials (11 to 250 people each) in adults with functional bowel disorders | Fiber supplements: agave fructans, acacia fiber, psyllium, nopal, pectin, resistant starch mixes and others Various 1 to 8 weeks · vs Placebo or control |
Results varied. Seven studies reported better symptoms and one reported worse symptoms. Agave fructans improved constipation but worsened flatulence. Acacia fiber improved stool frequency. One study reported worse quality of life with the fiber. Narrative summary, no pooled result (Not applicable) Methods, limits and fundingOutcomes: Symptom severity, quality of life Limitations: High differences between trials prevented pooling. Small, short trials. Only 2 of 10 were low risk of bias. Funding and conflicts: Not stated in the abstract. Read: abstract |
| So 2018 Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr · PMID 29757343 · DOI |
Systematic review meta analysis |
2099 64 randomised trials in healthy adults |
Dietary fibers of many types (fructans and galacto-oligosaccharides were subgroups) Various · vs Placebo or low-fiber comparator |
Fiber raised Bifidobacterium (SMD 0.64) and Lactobacillus (SMD 0.22). Fructans and galacto-oligosaccharides gave the clearest rises. Overall bacterial diversity did not change. Bifidobacterium SMD 0.64; Lactobacillus SMD 0.22 (95% CI 0.42 to 0.86; 0.03 to 0.41) Methods, limits and fundingOutcomes: Gut bacteria abundance and diversity; fecal short-chain fatty acids Limitations: Bacteria counts are markers. Healthy adults only. Many fiber types were pooled. Funding and conflicts: Not stated in the abstract. Registration: PROSPERO CRD42016053101 Read: abstract |
| Staudacher 2026 Fiber Supplementation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Gastroenterology · PMID 42600900 · DOI |
Systematic review meta analysis |
1904 30 randomised trials in adults with IBS (wheat bran 7, psyllium 6, inulin-type fructans 5, beta-GOS 2) |
Fiber supplements Various · vs Placebo |
52% responded to fiber and 44% to control (RR 1.21), with a clear benefit for psyllium (RR 1.53). Overall symptom scores did not change significantly, except for beta-galacto-oligosaccharides, which improved them. Response RR 1.21 overall; RR 1.53 psyllium; overall symptoms SMD -0.25 (not significant) (95% CI 1.03 to 1.41; 1.06 to 2.19; -0.67 to 0.17) Methods, limits and fundingOutcomes: Clinical response; overall gut symptoms Limitations: Large differences between trials for symptom scores (I2 78%). Only 2 trials of beta-GOS. Subtypes of IBS could not be separated. Funding and conflicts: Not stated in the abstract. Registration: PROSPERO CRD42024600758 Read: abstract |
| Van den Houte 2024 Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome. Gastroenterology · PMID 38401741 · DOI |
Randomized controlled trial |
117 117 people with IBS who had responded to a low FODMAP diet |
Six FODMAP powders (fructans, fructose, galacto-oligosaccharides, lactose, mannitol, sorbitol) versus glucose 9 weeks of blinded reintroduction · vs Glucose |
Symptoms returned in 85% of FODMAP powders. Most common triggers were fructans (56%) and mannitol (54%), then galacto-oligosaccharides (35%), lactose, fructose, sorbitol and glucose (26%). Fructans 56%; GOS 35%; glucose 26% (Not given in the abstract) Methods, limits and fundingOutcomes: Return of IBS symptoms (rise of 50 or more points) Limitations: Tertiary-care people who had already responded to a low FODMAP diet. Single challenges, not daily supplements. Funding and conflicts: Not stated in the abstract. Registration: NCT04373304 Read: abstract |
| Williams 2022 The Effects of Prebiotics, Synbiotics, and Short-Chain Fatty Acids on Respiratory Tract Infections and Immune Function: A Systematic Review and Meta-Analysis. Adv Nutr · PMID 34543378 · DOI |
Systematic review meta analysis |
58 studies, mostly randomised trials in infants and children | Prebiotics (mainly oligosaccharides), synbiotics and short-chain fatty acids Various · vs Placebo |
Fewer people had at least one respiratory infection with prebiotics (odds ratio 0.73, 17 trials). The authors say this is mostly in infants and children, with less evidence in adults. Effects on immune cell types were less clear. Respiratory infection OR 0.73 (prebiotics) (95% CI 0.62 to 0.86) Methods, limits and fundingOutcomes: Respiratory infections; immune markers such as natural killer cell activity Limitations: Mostly infants and children, mostly oligosaccharides. No certainty rating in the abstract. Reporting of infections can be unreliable. Funding and conflicts: Not stated in the abstract. Registration: PROSPERO CRD42019118786 Read: abstract |
| Wu 2024 The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients · PMID 38999862 · DOI |
Systematic review meta analysis |
Adults with IBS; 54 trials of probiotics, 7 of prebiotics or synbiotics, 6 of fecal transplant | Prebiotics and synbiotics (compared with probiotics and fecal transplant) Various · vs Placebo |
Probiotics and fecal transplant improved IBS symptoms. Prebiotics and synbiotics did not show significant improvement. Probiotics OR 0.53; prebiotics and synbiotics not significant (Probiotics 95% CI 0.48 to 0.59) Methods, limits and fundingOutcomes: IBS symptoms Limitations: Only 7 trials of prebiotics or synbiotics, pooled together. Not specific to one fiber. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Xiong 2021 Effects of resistant starch on glycaemic control: a systematic review and meta-analysis. Br J Nutr · PMID 32959735 · DOI |
Systematic review meta analysis |
19 randomised trials of resistant starch (type 1 and mixtures excluded) | Resistant starch versus digestible starch Subgroups: more than 28 g a day, and more than 8 weeks Various · vs Digestible starch |
Fasting glucose was slightly lower with resistant starch. HOMA-IR fell. Fasting insulin and several other insulin measures did not change. Fasting glucose -0.09 mmol/L; HOMA-IR -0.33 (95% CI -0.13 to -0.04; -0.51 to -0.14) Methods, limits and fundingOutcomes: Fasting glucose, insulin and insulin-resistance measures Limitations: The fall in glucose is small. The authors call the effect 'moderate'. People studied varied. The review does not give a certainty rating. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Yasukawa 2019 Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial. Nutrients · PMID 31509971 · DOI |
Randomized controlled trial |
44 44 healthy volunteers with a tendency toward loose stools |
Partially hydrolyzed guar gum (PHGG) 3 months · vs Placebo |
Stool form moved toward normal compared with placebo. Stool frequency did not change. Bifidobacterium rose in the PHGG group. Stool form improved; Bifidobacterium p<0.05 (Not given in the abstract) Methods, limits and fundingOutcomes: Stool form (Bristol scale), stool frequency, gut bacteria Limitations: Small trial in healthy people with loose stools, not in a disease. Funding not stated in the abstract. Funding and conflicts: Not stated in the abstract. Read: abstract |
| s-isapp-prebiotics ISAPP: Prebiotics (resource page) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-nhs-laxatives NHS: Laxatives (page last reviewed 30 April 2026) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-gas NIDDK: Symptoms and causes of gas in the digestive tract (last reviewed June 2021) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text |
What we do not know yet
- No trial was read showing that a prebiotic fiber improves a health outcome in people with a gut disorder, apart from the mixed IBS results above.
- Which fiber, chain length or product works best was not shown.
- Whether a higher Bifidobacterium count leads to any health benefit was not shown.
- Long-term safety and safety in pregnancy, breastfeeding and weakened immunity were not covered.
- No interaction study with named medicines was found.
- Per-portion prebiotic content of foods was not found.
How new research is added
New studies are found by a saved PubMed search and placed in a review queue before the page changes.
Lab markers
What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".
Metabolic 1
Fasting blood glucose
Slightly lower in trials
Blood sugar after not eating overnight.
Low certaintyResults and what it means
Why it was measured
To see whether resistant starch helps blood sugar control.
Statistical vs. clinical meaning
A small change in a lab marker; it has not been tied to fewer health problems.
Safety implication
People using diabetes medicines should ask a pharmacist before adding fiber products.
| Study | Result | People | Product |
|---|---|---|---|
| 19 | -0.09 mmol/L (95% CI -0.13 to -0.04); larger in trials with higher amounts and in trials over 8 weeks | 19 randomised trials | Resistant starch versus digestible starch |
Other 7
Bifidobacterium in stool
Higher in most trials in trials
How much of the Bifidobacterium group of gut bacteria is in a stool sample.
Low certaintyResults and what it means
Why it was measured
Prebiotics are sold to feed these bacteria.
Statistical vs. clinical meaning
A marker only. A higher count has not been shown to improve symptoms or health.
Safety implication
Gas and bloating are common as bacteria ferment these fibers.
| Study | Result | People | Product |
|---|---|---|---|
| 12 | Standardised mean difference 0.83 (95% CI 0.58 to 1.08), 50 trials | 2,525 people aged 0 to 83; no rise in people with gut disorders | Chicory inulin-type fructans for at least 7 days |
| 5 | Weighted mean difference 0.579 (95% CI 0.444 to 0.714), 8 trials | 388 adults and infants | Fructooligosaccharides |
| 14 | SMD 0.64 (95% CI 0.42 to 0.86), 64 trials | 2,099 healthy adults | Dietary fibers; clearest for fructans and GOS |
Bowel movements per week
Higher in some trials in trials
How often a person has a bowel movement.
Low certaintyResults and what it means
Why it was measured
To see whether prebiotics work as mild regularity aids.
Statistical vs. clinical meaning
A modest change that fades in longer trials and varies by fiber.
Safety implication
Gas and bloating can make people stop.
Stool form (Bristol scale)
Better in one trial, no change in others in trials
How hard or loose a stool is, rated on a seven-point picture scale.
Low certaintyResults and what it means
Why it was measured
To see whether fibers normalise loose or hard stools.
Statistical vs. clinical meaning
Small single trials with different results.
Safety implication
None specific.
Stool pH
Lower in trials
How acidic stool is. Fermentation of fibers makes it more acidic.
Low certaintyResults and what it means
Why it was measured
A marker that bacteria are fermenting the fiber.
Statistical vs. clinical meaning
A fermentation marker only. Short-chain fatty acid results in the same review were inconclusive.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 3 | SMD -1.02 (95% CI -1.25 to -0.79) | 20 trials, 1,786 people | Non-digestible oligosaccharides |
Insulin resistance score (HOMA-IR)
Lower in trials
A calculated score from fasting glucose and insulin that estimates how well the body responds to insulin.
Low certaintyResults and what it means
Why it was measured
To see whether resistant starch changes insulin response.
Statistical vs. clinical meaning
A calculated estimate, not a direct test.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 19 | -0.33 (95% CI -0.51 to -0.14); fasting insulin and HOMA-beta did not change | 19 randomised trials | Resistant starch versus digestible starch |
People with at least one respiratory infection
Fewer with prebiotics in trials
Whether a person had a cold or other respiratory infection during the study.
Low certaintyResults and what it means
Why it was measured
To see whether prebiotics protect against infections.
Statistical vs. clinical meaning
A real health outcome, but mostly in children and with reporting limits.
Safety implication
Ask a doctor before giving prebiotics to children.
| Study | Result | People | Product |
|---|---|---|---|
| 17 | Odds ratio 0.73 (95% CI 0.62 to 0.86), 17 comparisons | Mostly infants and children | Prebiotics (mainly oligosaccharides) versus placebo |
Infant stool pH
Lower with prebiotic formula in trials
How acidic baby stool is.
Low certaintyResults and what it means
Why it was measured
A marker of bacterial fermentation in the infant gut.
Statistical vs. clinical meaning
A marker only.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 9 | Mean difference -0.39 (95% CI -0.57 to -0.20), 7 comparisons | Formula-fed infants aged 6 months or less | Prebiotic-supplemented formula versus standard formula |
Safety
What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.
Main points to know 5
- Gas and bloating are common. Gut bacteria ferment these fibers, and that makes gas. A 2022 review of trials in adults without gut disease found tolerance depended on the specific fiber. Of 17 FOS and oligofructose trials, 7 reported gas, and higher amounts caused more. In 5 long-term GOS trials, tolerance did not differ from control. A meta-analysis of FOS found no difference from control in gut symptoms. NIDDK says undigested carbohydrates are broken down by bacteria in the large intestine, which creates gas. Systematic reviews and authoritative guidance 11 5 23
- They can set off symptoms in irritable bowel syndrome (IBS). Fructans (the family with inulin and FOS) were the most common trigger (56%) when 117 people with IBS were retested food by food in a blinded trial, and GOS triggered symptoms in 35%. In 29 adults with IBS who drank inulin, 13 reached a symptom threshold against 6 after glucose. The authors point to a gut that is more sensitive to stretching, rather than more gas. If you have IBS or know FODMAPs upset you, ask a doctor or dietitian first. Randomised trials 16 10
- FOS did not help Crohn's disease, and more people dropped out. In 103 people with active Crohn's disease, FOS gave no clinical benefit over placebo in 4 weeks. 26% of people on FOS left the trial early, against 8% on placebo. People with Crohn's disease or ulcerative colitis should ask their gut specialist before using fiber supplements. Randomised trial 1
- Fructans worsened symptoms in some children with IBS. In a crossover trial of 23 children with IBS, a fructan-containing diet brought more abdominal pain (3.4 against 2.4 episodes a day), more bloating and more gas than a placebo. 12 of the 23 children were fructan-sensitive, and usual symptoms did not predict who would react. Randomised crossover trial 4
- Allergy to inulin-containing foods is rare but reported. A woman with a past artichoke allergy had a severe anaphylactic reaction after eating two health foods containing inulin; tests suggested the reaction was to inulin bound to protein. This is a single case report; how often it happens is not known. Case report 6
Side effects 4
| Effect | How often | Severity and recovery | Evidence |
|---|---|---|---|
| Gas (flatulence), bloating and rumbling Tolerance is specific to each fiber; a result for one does not carry over to another. | Gas in 7 of 17 FOS and oligofructose trials (2022 review). A 2022 FOS meta-analysis found no difference from control in gut symptoms. Frequency in individual people was not given in the abstracts read. | Mild to excessive, depending on the fiber and the amount Not described in the sources read. | Systematic reviews 11 5 23 |
| Worse IBS symptoms (pain, bloating) Single large drinks and food challenges, not daily supplements. | Fructans triggered symptoms in 56% and GOS in 35% of 117 people with IBS; 13 of 29 reached a symptom threshold after an inulin drink; 12 of 23 children were fructan-sensitive. | Symptom flare measured on symptom scores Abdominal pain rose by about day 2 for fructans and GOS in the reintroduction trial; recovery time was not described in the abstracts. | Randomised trials 16 10 4 |
| Leaving a trial early (Crohn's disease) The abstract does not give reasons for leaving. | 14 of 54 on FOS against 4 of 49 on placebo left before week 4. | Not described in the abstract. Not described. | Randomised trial 1 |
| Allergic reaction including anaphylaxis (inulin) Inulin and chicory fiber are added to many bars, yogurts and drinks, so people who react should read labels. | One reported case; how common it is is not known. | Severe in the case reported Not described in the abstract. | Case report 6 |
Liver
No liver injury from prebiotic fibers was found in the sources read. A liver-safety reference (LiverTox) was not opened for this page.
How often. No frequency was found.
Monitoring. No agency monitoring advice was found.
This is a safety connection. It is not evidence that Prebiotic fibers supports liver health.
Medicines and supplements 5
| With | Why it matters | Importance | Evidence | What to do |
|---|---|---|---|---|
| Diabetes medicines (insulin, tablets) prescription | Resistant starch lowered fasting glucose slightly in a 2021 meta-analysis, so an added effect on blood sugar is possible. No interaction study was read. | Unknown; a possible small added effect on blood sugar. | Inferred from trials of blood sugar markers Very low certainty 19 | Ask a pharmacist or doctor before adding a fiber product if you use diabetes medicines. |
| Laxatives and other bowel medicines prescription and over the counter | Prebiotic fibers can change stool frequency. In one care-home trial, laxative use fell on PHGG. No study of interactions with laxatives or anti-diarrhea medicines was read. | Unknown. | None found Not enough evidence 2 | Ask a pharmacist before combining a fiber product with laxatives or anti-diarrhea medicines. |
| Probiotics (synbiotic products) supplement | Prebiotics are often sold with probiotics. A 2024 analysis found prebiotics and synbiotics did not significantly improve IBS symptoms. No harmful interaction between them was reported in the abstracts read. | No interaction harm found; benefit of the combined product is not shown in IBS. | Network meta analysis Low certainty 18 | A synbiotic needs evidence for that exact product. Ask a pharmacist. |
| Other fermentable fibers and high-FODMAP foods food and supplement | Fructans, GOS, lactose, mannitol, sorbitol and fructose all triggered symptoms in the IBS reintroduction trial, so several together can add up. | More gas or pain in sensitive people. | Randomised trial Low certainty 16 | If you are sensitive, a dietitian can help sort out which foods matter. |
| Minerals such as calcium supplement | A 2022 review says FOS, oligofructose and GOS have been shown to improve mineral and calcium absorption at some amounts. No harm from this was reported in the review text read; no interaction safety study was read. | Described as a possible benefit, not a risk. | Review statement Not enough evidence 11 | Ask a pharmacist if you take several mineral products. |
Who should check first 6
| Situation | Advice | Evidence |
|---|---|---|
| Irritable bowel syndrome or known FODMAP sensitivity | Fructans and GOS triggered symptoms in many people with IBS. Ask a doctor or dietitian before using prebiotic fibers. | Randomised trials 16 10 4 |
| Crohn's disease, ulcerative colitis or a bowel blockage | A trial of FOS in active Crohn's disease showed no benefit and more dropouts. The NHS lists Crohn's disease, ulcerative colitis and a blocked bowel among the reasons to check with a pharmacist or doctor before laxatives (a general laxatives page, not about prebiotics). Ask a clinician first. | Randomised trial and authoritative guidance (general) 1 22 |
| Pregnancy and breastfeeding | The NHS says to check with a pharmacist or doctor before laxatives if pregnant or breastfeeding (general page). No safety study of prebiotic supplements in pregnancy or breastfeeding was found in the sources read. | Authoritative guidance (general); none found for prebiotic supplements 22 |
| Infants and children | Prebiotics added to infant formula raised Bifidobacterium without harming growth in a 2025 review, but that concerns regulated formula, not supplements, and the abstract does not describe side effects. In children with IBS, fructans worsened symptoms in some. Ask a pediatrician before giving any fiber or prebiotic product to a baby or child. | Systematic review and randomised trial 9 4 |
| Allergy to inulin, chicory or artichoke | A single case report links an inulin-containing food to anaphylaxis in a woman with an artichoke allergy. Read labels and ask an allergist if you have reacted before. | Case report 6 |
| Weakened immune system or serious illness | No source read covered prebiotic safety in people with weakened immunity. Ask the team caring for you before using any gut-flora product. | None found |
Overdose, product quality and regulators
Summary. Prebiotic fibers are food fibers, and a 2022 review lists inulin, FOS, oligofructose and GOS among the fibers the US FDA accepts as dietary fibers. The effect seen in trials is gut discomfort, not poisoning. No toxic effect was found in the sources read.
Animal. Not reviewed.
High dose or long term signals. In the 2022 review, higher amounts of some fibers caused excessive gas, rumbling, bloating and, at the largest amounts, diarrhea and cramps. Long-term use was not covered in the sources read.
Overdose response. Not described beyond gut symptoms in the sources read.
Genotoxicity. Not researched.
Contamination and label accuracy of prebiotic supplements were not researched for this page.
The word 'prebiotic' on a label. The 2017 ISAPP consensus statement says a health benefit must be documented before a substance counts as a prebiotic, and the ISAPP page says not all dietary fibers are prebiotics. A label that says 'prebiotic' does not by itself show that this product has been tested. 7 21
Hidden prebiotic fibers in processed foods. The anaphylaxis case report involved two health foods that contained inulin. Inulin and similar fibers are added to bars, yogurts and drinks, so people who react should read labels. 6
Which fiber a product contains. Reviews are specific to chicory inulin, FOS, GOS, PHGG, acacia fiber or resistant starch. Chain length and type differ, so results for one cannot be applied to every product. 11
| Body | Action | Date |
|---|---|---|
| ISAPP (International Scientific Association for Probiotics and Prebiotics) (International) | Its 2017 consensus statement defines a prebiotic as a substrate selectively used by host microorganisms that gives a health benefit, and requires documented beneficial effects. source | 2017-08-01 |
| NIDDK (US National Institute of Diabetes and Digestive and Kidney Diseases) (United States) | Explains that bacteria in the large intestine break down undigested carbohydrates and create gas, and advises talking to a doctor if gas symptoms bother you, change suddenly or come with pain, constipation, diarrhea or weight loss. source | 2021-06-01 |
| NHS / UK National Health Service (United Kingdom) | Its laxatives page says to check with a pharmacist or doctor before using laxatives if you are pregnant or breastfeeding or have a digestive condition such as Crohn's disease or ulcerative colitis. This is a general laxatives page, not about prebiotics. source | 2026-04-30 |
When to get medical help
- Swollen lips, tongue or throat, a raised itchy rash, wheeze or trouble breathing after eating or using a product with inulin, chicory or similar fibers: call emergency services.
- Severe belly pain, a swollen hard belly, repeated vomiting or being unable to pass wind or stool: get medical help straight away (possible bowel blockage).
- Blood in the stool, black stools or unexplained weight loss: see a doctor and do not self-treat with fiber.
- Gas, bloating or pain that keeps getting worse or lasts after stopping the product: stop and ask a doctor or pharmacist.
- A baby or young child with a swollen belly, repeated vomiting, blood in stool or fever after a new product: seek medical help.
Stop using the product and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.
General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.
Frequently asked questions
What are prebiotic fibers, and are they the same as probiotics?
Is every fiber a prebiotic?
Which foods contain prebiotics?
Do prebiotic fibers feed good gut bacteria?
Do they help constipation?
Are they good for IBS?
Why do they cause gas and bloating?
Who should be careful?
What is the difference between inulin, FOS and GOS?
Inulin and FOS are chains of fructose (inulin is longer). GOS is a set of short galactose chains made from lactose. They act in the same way in the gut but are tested separately. Inulin has its own page, linked below.
Does resistant starch lower blood sugar?
A little. A review of 19 trials found fasting glucose about 0.09 mmol/L lower than with digestible starch, and an insulin-resistance score lower, while other insulin measures did not change. It does not apply to other prebiotic fibers.
Are prebiotics safe for babies and children?
Do prebiotics help the immune system or colds?
There is a signal in children: a 2022 review found fewer respiratory infections with prebiotics (odds ratio 0.73), mostly in infants and children, with less evidence in adults.
Explore by health goal
Gut HealthDigestive SupportMicrobiome BalanceBlood Sugar BalanceMetabolic HealthImmune Support
Editorial transparency
- Written by
- AlternativeMed editorial team. Research compiled with AI assistance, then checked against the sources listed.
- Medical review
- None. This page has not been reviewed by a physician or pharmacist.
- First published
- 2026-10-26
- Last substantive update
- 2026-10-26
- How we research
- We started from our existing summary of prebiotic fibers, then re-read PubMed abstracts for reviews, trials and case reports, the open-access text of the 2022 tolerance review, and the ISAPP, NIDDK and NHS pages. Only abstracts were read for most studies.
- How we rate evidence
- See "How we rate evidence" in the Evidence tab.
- Independence
- No product is promoted on this page. No affiliate links are shown. Trials of fiber products may have manufacturer links not stated in abstracts.
Sources 23
Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.
- Benjamin JL, Hedin CR, Koutsoumpas A et al.. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.. Gut. 2011. PMID 21262918. DOI 10.1136/gut.2010.232025. (abstract)
- Chan TC, Yu VMW, Luk JKH et al.. Effectiveness of Partially Hydrolyzed Guar Gum in Reducing Constipation in Long Term Care Facility Residents: A Randomized Single-Blinded Placebo-Controlled Trial.. J Nutr Health Aging. 2022. PMID 35297467. DOI 10.1007/s12603-022-1747-2. (abstract)
- Chen H, Ren J, Wang L et al.. Non-Digestible Oligosaccharides and Constipation: A Systematic Review and Meta-Analysis of Randomized Trials on Stool Frequency, Stool Consistency, and Fermentation Biomarkers.. Nutrients. 2025. PMID 41156499. DOI 10.3390/nu17203246. (abstract)
- Chumpitazi BP, McMeans AR, Vaughan A et al.. Fructans Exacerbate Symptoms in a Subset of Children With Irritable Bowel Syndrome.. Clin Gastroenterol Hepatol. 2018. PMID 28970147. DOI 10.1016/j.cgh.2017.09.043. (abstract)
- Dou Y, Yu X, Luo Y et al.. Effect of Fructooligosaccharides Supplementation on the Gut Microbiota in Human: A Systematic Review and Meta-Analysis.. Nutrients. 2022. PMID 36014803. DOI 10.3390/nu14163298. (abstract)
- Franck P, Moneret-Vautrin DA, Morisset M et al.. Anaphylactic reaction to inulin: first identification of specific IgEs to an inulin protein compound.. Int Arch Allergy Immunol. 2005. PMID 15650313. DOI 10.1159/000083323. (abstract)
- Gibson GR, Hutkins R, Sanders ME et al.. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.. Nat Rev Gastroenterol Hepatol. 2017. PMID 28611480. DOI 10.1038/nrgastro.2017.75. (abstract)
- JanssenDuijghuijsen L, van den Belt M, Rijnaarts I et al.. Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial.. Eur J Nutr. 2024. PMID 38653808. DOI 10.1007/s00394-024-03398-8. (abstract)
- Kebbe M, Leung K, Perrett B et al.. Effects of Infant Formula Supplemented With Prebiotics on the Gut Microbiome, Gut Environment, Growth Parameters, and Safety and Tolerance: A Systematic Review and Meta-Analysis.. Nutr Rev. 2025. PMID 39832301. DOI 10.1093/nutrit/nuae184. (abstract)
- Major G, Pritchard S, Murray K et al.. Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome.. Gastroenterology. 2017. PMID 27746233. DOI 10.1053/j.gastro.2016.09.062. (abstract)
- Mysonhimer AR, Holscher HD. Gastrointestinal Effects and Tolerance of Nondigestible Carbohydrate Consumption.. Adv Nutr. 2022. PMID 36041173. DOI 10.1093/advances/nmac094. (full-text (open access, PMC9776669))
- Nagy DU, Sándor-Bajusz KA, Bódy B et al.. Effect of chicory-derived inulin-type fructans on abundance of Bifidobacterium and on bowel function: a systematic review with meta-analyses.. Crit Rev Food Sci Nutr. 2023. PMID 35833477. DOI 10.1080/10408398.2022.2098246. (abstract)
- Raked R, Ibrahim M, Utter J et al.. Fibre manipulation to manage symptom severity and quality of life in patients with functional bowel disorders: A systematic review.. Clin Nutr ESPEN. 2026. PMID 41525871. DOI 10.1016/j.clnesp.2025.102896. (abstract)
- So D, Whelan K, Rossi M et al.. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis.. Am J Clin Nutr. 2018. PMID 29757343. DOI 10.1093/ajcn/nqy041. (abstract)
- Staudacher HM, Rucco V, Mancell S et al.. Fiber Supplementation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Gastroenterology. 2026. PMID 42600900. DOI 10.1053/j.gastro.2026.07.027. (abstract)
- Van den Houte K, Colomier E, Routhiaux K et al.. Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome.. Gastroenterology. 2024. PMID 38401741. DOI 10.1053/j.gastro.2024.02.008. (abstract)
- Williams LM, Stoodley IL, Berthon BS et al.. The Effects of Prebiotics, Synbiotics, and Short-Chain Fatty Acids on Respiratory Tract Infections and Immune Function: A Systematic Review and Meta-Analysis.. Adv Nutr. 2022. PMID 34543378. DOI 10.1093/advances/nmab114. (abstract)
- Wu Y, Li Y, Zheng Q et al.. The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.. Nutrients. 2024. PMID 38999862. DOI 10.3390/nu16132114. (abstract)
- Xiong K, Wang J, Kang T et al.. Effects of resistant starch on glycaemic control: a systematic review and meta-analysis.. Br J Nutr. 2021. PMID 32959735. DOI 10.1017/S0007114520003700. (abstract)
- Yasukawa Z, Inoue R, Ozeki M et al.. Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial.. Nutrients. 2019. PMID 31509971. DOI 10.3390/nu11092170. (abstract)
- . ISAPP: Prebiotics (resource page). . . (full-text)
- . NHS: Laxatives (page last reviewed 30 April 2026). . . (full-text)
- . NIDDK: Symptoms and causes of gas in the digestive tract (last reviewed June 2021). . . (full-text)
Where to buy
Check the label first. Whatever you buy, look for these:
- The amount of the active ingredient per serving, not just the front-label claim
- A third-party testing mark (USP, NSF or ConsumerLab)
- Other ingredients and allergens
- Ask a pharmacist about interactions with your medicines
Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.
Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.